Growth Metrics

Cannabis Bioscience International Holdings (CBIH) Receivables - Net (2023 - 2026)

Cannabis Bioscience International Holdings' Receivables - Net history spans 4 years, with the latest figure at $1266.0 for Q1 2026.

  • On a quarterly basis, Receivables - Net fell 52.05% to $1266.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $1266.0, a 52.05% decrease, with the full-year FY2025 number at $6380.0, down 68.32% from a year prior.
  • Receivables - Net hit $1266.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $21811.0 in the prior quarter.
  • Over the last five years, Receivables - Net for CBIH hit a ceiling of $21811.0 in Q4 2025 and a floor of $1266.0 in Q1 2026.
  • Historically, Receivables - Net has averaged $12599.3 across 4 years, with a median of $13819.0 in 2024.
  • Biggest five-year swings in Receivables - Net: skyrocketed 102.38% in 2024 and later crashed 84.51% in 2025.
  • Tracing CBIH's Receivables - Net over 4 years: stood at $19403.0 in 2023, then fell by 28.78% to $13819.0 in 2024, then skyrocketed by 57.83% to $21811.0 in 2025, then plummeted by 94.2% to $1266.0 in 2026.
  • Business Quant data shows Receivables - Net for CBIH at $1266.0 in Q1 2026, $21811.0 in Q4 2025, and $8966.0 in Q3 2025.